PharmaTelevision - BioCat: Funding and Future Goals for Catalonian Biotechs

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BioCat: Funding and Future Goals for Catalonian Biotechs

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks with Montserrat Vendrell, at BioCat. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss:

• The origins of BioCat

• How BioCat obtains its funds

• The biotech sector in Catalonia

• BioCat's objectives

• VC funding in Catalonia

• The importance of events like BioEurope for Catalonian biotechs

• BioCat's hopes for for the next 5 years

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

The origins of BioCat.

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at BioEurope in Barcelona. On this show I have Montserrat Vendrell, who is the CEO of BioCat a local biotechnology association here based in Barcelona, welcome.

Montserrat Vendrell:

Thank you very much, pleasure.

Fintan Walton:

BioCat is an organization that was set up about four-years ago tell us about how the origins of BioCat came about and what were the driving forces for the origins of that organization?

Montserrat Vendrell:

BioCat is actually a cluster organization we are a foundation and the origins were pretty much a broader map approach different stake holders in the biotech arena in Catalonia realized that we had several assets that could make biotechnology specially focusing towards the health sector an important economic driver for our region. So science parks, research centers, hospitals and companies got together and asked the government for the need to create an entity such as BioCat to promote this sector sectorally and address both operative in strategic levels to needs of promoting the sector.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Montserrat Vendrell

Chief Executive Officer

Dr. Montserrat Vendrell i Rius has been appointed by the board of trustees of the Private Foundation BioCat (The BioRegion of Catalonia), and the President of Catalonia; Honorable Jose Montilla, as the CEO of BioCat, in 2007. Montserrat Vendrell holds a Ph.D. degree in Biology from the University of Barcelona and has more than a 10 years of experience in biomedical and biotech research. As a postdoctoral fellow, Dr. Vendrell researched at the Roche Institute of Molecular Biology of New Jersey (USA) and The Institute of Molecular Biology of Barcelona, CSIC. She holds a Science Communication Masters degree (UPF, 1997) and a General Management Program (IESE, 2007). She has been the vice-president of the Catalan Society for Biology since 2003.

BioCat

BioCat is the organization that coordinates dynamizes and promotes biotechnology, biomedicine and medical technology sector in Catalonia. It is fostered by the Government of Catalonia and the Barcelona City Council and, since it was created in 2006, has included companies and organizations from this sector in its governing bodies.